71 results
Page 4 of 4
UPLOAD
epu9cm
8 May 19
Letter from SEC
12:00am
DEF 14A
oucw4xck3hce
26 Apr 19
Definitive proxy
5:00pm
10-K
d8h2fr0u
28 Feb 19
Annual report
1:08pm
424B5
3qu31vkuhlmun78
25 Jan 19
Prospectus supplement for primary offering
8:01am
424B5
9vx6he5mha26z4ol3ho3
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
hq7rnd7ibr2p7
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
6-K
EX-99.1
7xd5ap6 nj
31 Oct 18
UGN-101 Joins Select Group of Urologic Oncology Product Candidates to Receive BTD
3:36pm
UPLOAD
odbpp51ubmy h7g
24 Oct 18
Letter from SEC
12:00am
6-K
EX-99.1
mk3a o9ah25
8 Aug 18
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
1:46pm
20-F
r8g 3geoq
15 Mar 18
Annual report (foreign)
12:00am
424B4
tsmmfq7vjm6o8pjr
22 Jan 18
Prospectus supplement with pricing info
12:00am